Skip to main content

Table 2 Logistic Regression of Factors Associated with HIVAN, entire cohort

From: HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study

  P value Adjusted odds ratio for HIVAN 95% CI
Age <48 (vs. > = 71)* 0.005 9.35 1.99, 43.48
Serum albumin (per higher quartile) <0.001 0.31 0.15, 0.69
Male (vs. female) 0.001 6.58 2.39, 18.11
African American <0.001 11.03 4.09, 27.78
CCB use (vs. other medications) 0.02 0.23 0.07, 0.75
Malnourished (vs. adequate nutrition) 0.001 4.09 1.56, 10.72
Smoking (vs. non active smoking) 0.02 2.89 1.16, 7.18
  1. HIVAN=Human immunodeficiency virus associated nephropathy. *Other age categories were not statistically significant when compared to age > = 71 years Nagelkerke r2 was 0.50, c-statistic was 0.97 (95% CI, 0.96, 0.99)